Welcome to After Market, the podcast from Proactive Australia with its finger firmly on the investor pulse.
Each month we take a closer look at the issues shaping and shifting the markets - from cost of living to climate, geopolitics to geology, macroeconomics to medtech and big data to battery metals.
Please note that the views of our interviewees are not the views of Proactive Investors. Seek independent investment advice before making any financial decisions and remember that nothing you hear on this pod constitutes investment advice.
ASX companies turn to OTC Markets for dual listing
OTC Markets Group executive vice president Jason Paltrowitz discusses with Proactive how ASX companies use OTC Markets for dual listings, which allows them to access U.S. investors without full U.S. regulatory compliance in this interview.
28 Mar 2025
Safer chemotherapy? Race Oncology’s new drug heads to trials
Race Oncology Ltd is advancing the development of a reformulated chemotherapy drug aimed at reducing severe side effects, particularly cardiac-related risks, while preserving or improving efficacy. In this episode of After Market with Jonathan Jackson, CEO and managing director Daniel Tillett highlighted the drug’s potential to work alongside anthracyclines, a common class of chemotherapy agents, to enhance patient safety and treatment outcomes. The company is preparing for clinical trials to evaluate the drug’s performance in human subjects.
28 May 2024
The state of drug development in Australia: a case study
Amplia Therapeutics Ltd CEO and managing director Dr Chris Burns has had a long career in drug development, including discovering only the second Australian drug to receive US FDA approval. He has plenty of advice to share for Australian-based researchers and domestically developed biotech assets. Proactive's Susanna Nelson chats to him about the current state of clinical research and commercial drug development in Australia.
Podcast Authority Score: 18 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
25
Social presence
0
YouTube
0
Engagement
27
Host of After Market?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
